Physician profile
Mark E Farmer
NPI 1821068545
$7,266.57
in general payments reported to CMS, 2019-2025
23 companies · $4,759 in 2025
The $4,759 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $210 · 2021: $52.38 · 2022: $164 · 2023: $171 · 2024: $1,704 · 2025: $4,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,315 · Long Term Medical Supply Or Device Loan: $1,970 · Food and Beverage: $1,044 · Consulting Fee: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,314.71 |
| Long Term Medical Supply Or Device Loan | $1,969.74 |
| Food and Beverage | $1,043.66 |
| Consulting Fee | $305.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,033.70 | 2025 | Actify 3d, Actify 3d |
| Integra Lifesciences Corporation | $1,969.74 | 2025 | Biodfactor |
| Ortho Development Corporation | $1,110.18 | 2024 | |
| Zimmer Biomet Holdings, INC. | $550.86 | 2024-2025 | Oxford, Mymobility Platform |
| Stryker Corporation | $322.43 | 2020-2025 | Reunion, Variax, Pangea |
| Hikma Pharmaceuticals USA | $305.33 | 2024 | Combogesic IV |
| Cms Imaging, INC. | $185.65 | 2022-2023 | |
| Heron Therapeutics, INC. | $143.37 | 2022-2024 | Zynrelef |
| Amgen INC. | $135.67 | 2019-2023 | Evenity, Prolia |
| Vertex Pharmaceuticals Incorporated | $120.10 | 2025 | |
| Pacira Therapeutics, INC. | $110.91 | 2019-2021 | |
| Mml US, INC. | $42.18 | 2025 | Reactiv8 |
| Bioventus LLC | $38.24 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Djo, LLC | $31.35 | 2024 | Cmf |
| Orthogenrx INC. | $23.80 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $22.94 | 2021-2023 | Palacos |
| Abbvie INC. | $20.85 | 2023 | |
| Orthofix Medical, INC. | $20.70 | 2022 | |
| Linvatec Corporation | $19.19 | 2022 | |
| Boston Scientific Corporation | $19.04 | 2023 | Superion Indirect Decompression System |
| Ferring Pharmaceuticals INC. | $17.76 | 2021 | |
| Biocomposites INC | $15.05 | 2019 | |
| Fidia Pharma USA INC. | $7.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.